Herpes simplex virus type-2 (HSV-2) suppressive therapy to reduce genital and plasma HIV-1 RNA: overview of ANRS1285 trials, potential mechanisms and future interventions.

Citation

Mayaud, P.; Ouedraogo, A.; Nagot, N.; Konate, I.; Vergne, L.; Weiss, H.A.; Sanon, A.; van de Perre, P. Herpes simplex virus type-2 (HSV-2) suppressive therapy to reduce genital and plasma HIV-1 RNA: overview of ANRS1285 trials, potential mechanisms and future interventions. (2006)

Herpes simplex virus type-2 (HSV-2) suppressive therapy to reduce genital and plasma HIV-1 RNA: overview of ANRS1285 trials, potential mechanisms and future interventions.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.